EPIM
TMO icon

Evelyn Partners Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Evelyn Partners Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$53.6M Buy
109,140
+4,783
+5% +$2.6M 1.46% 17
2025
Q4 		$60.5M Sell
104,357
-477
-0.5% -$270K 1.67% 16
2025
Q3 		$50.8M Sell
104,834
-2,096
-2% -$976K 1.44% 17
2025
Q2 		$43.4M Sell
106,930
-39,313
-27% -$16.4M 1.33% 18
2025
Q1 		$72.8M Buy
146,243
+6,391
+5% +$3.46M 2.42% 11
2024
Q4 		$72.8M Buy
+139,852
New +$76.9M 2.36% 12

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Evelyn Partners Investment Management's TMO Position: Q1 2026 in Review

Evelyn Partners Investment Management increased its Thermo Fisher Scientific (TMO) stake by 4.6% in Q1 2026, buying an estimated $2.6M and bringing the position to 109,140 shares worth $53.6M. The position accounts for 1.46% of the portfolio, ranked #17.

Evelyn Partners Investment Management first reported a position in TMO in Q4 2024 and has held it in 6 quarters since. The position peaked at $72.8M in Q1 2025. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Evelyn Partners Investment Management held 109,140 shares of Thermo Fisher Scientific worth $53.6M as of Q1 2026.
  • Evelyn Partners Investment Management bought 4,783 Thermo Fisher Scientific shares in Q1 2026, an estimated $2.6M.
  • Thermo Fisher Scientific made up 1.46% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #17 holding.
  • Evelyn Partners Investment Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management's Thermo Fisher Scientific position peaked at $72.8M in Q1 2025.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.